- Home
- NRXP vs CLST Comparison
NRXP vs CLST Comparison
Compare NRXP & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- CLST
- Stock Information
- Founded
- NRXP 2015
- CLST 1922
- Country
- NRXP United States
- CLST United States
- Employees
- NRXP N/A
- CLST N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- CLST
- Sector
- NRXP Health Care
- CLST
- Exchange
- NRXP Nasdaq
- CLST Nasdaq
- Market Cap
- NRXP 58.5M
- CLST 51.8M
- IPO Year
- NRXP N/A
- CLST N/A
- Fundamental
- Price
- NRXP $2.89
- CLST $12.60
- Analyst Decision
- NRXP Strong Buy
- CLST
- Analyst Count
- NRXP 4
- CLST 0
- Target Price
- NRXP $28.50
- CLST N/A
- AVG Volume (30 Days)
- NRXP 283.3K
- CLST 2.5K
- Earning Date
- NRXP 08-19-2025
- CLST 07-24-2025
- Dividend Yield
- NRXP N/A
- CLST N/A
- EPS Growth
- NRXP N/A
- CLST N/A
- EPS
- NRXP N/A
- CLST 0.58
- Revenue
- NRXP N/A
- CLST $11,354,000.00
- Revenue This Year
- NRXP N/A
- CLST N/A
- Revenue Next Year
- NRXP $230.95
- CLST N/A
- P/E Ratio
- NRXP N/A
- CLST $21.75
- Revenue Growth
- NRXP N/A
- CLST 164.54
- 52 Week Low
- NRXP $1.10
- CLST $10.67
- 52 Week High
- NRXP $6.01
- CLST $14.23
- Technical
- Relative Strength Index (RSI)
- NRXP 54.48
- CLST 59.79
- Support Level
- NRXP $2.30
- CLST $12.51
- Resistance Level
- NRXP $2.68
- CLST $12.66
- Average True Range (ATR)
- NRXP 0.19
- CLST 0.06
- MACD
- NRXP 0.02
- CLST 0.01
- Stochastic Oscillator
- NRXP 89.39
- CLST 76.63
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.